Evidence map›Paper›PMID 40282438›Full record

ArticleCancers2025

Real-World Data on the Efficacy of Daratumumab in Patients with Relapsed/Refractory Multiple Myeloma and Amplification 1q.

Magdalena Benda, Patrick Reimann, Elena Bletzacher, Axel Muendlein, Benda Bernhard, Bernd Hartmann, Minh Huynh, Klaus Gasser, Niklas Zojer, Theresia Lang and 11 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Magdalena BendaDepartment of Internal Medicine II, Feldkirch Academic Teaching Hospital, 6800 Feldkirch, Austria.
Patrick ReimannDepartment of Internal Medicine II, Feldkirch Academic Teaching Hospital, 6800 Feldkirch, Austria.
Elena BletzacherDepartment of Internal Medicine V, Comprehensive Cancer Center Innsbruck, Medical University of Innsbruck, 6020 Innsbruck, Austria.
Axel MuendleinMolecular Biology Laboratory, Vorarlberg Institute for Vascular Investigation and Treatment, 6850 Dornbirn, Austria.
Benda BernhardCore Facility Internal Emergency and Intensive Care Medicine, University Clinic Innsbruck, 6020 Innsbruck, Austria.
Bernd HartmannDepartment of Internal Medicine II, Feldkirch Academic Teaching Hospital, 6800 Feldkirch, Austria.
Minh HuynhDepartment of Internal Medicine II, Feldkirch Academic Teaching Hospital, 6800 Feldkirch, Austria.
Klaus GasserDepartment of Internal Medicine II, Feldkirch Academic Teaching Hospital, 6800 Feldkirch, Austria.
Niklas ZojerDepartment of Internal Medicine II, Feldkirch Academic Teaching Hospital, 6800 Feldkirch, Austria.
Theresia LangDepartment of Internal Medicine II, Feldkirch Academic Teaching Hospital, 6800 Feldkirch, Austria.
Georg GöbelDepartment of Medical Statistics, Informatics and Health Economics, Medical University of Innsbruck, 6020 Innsbruck, Austria.
Jan-Paul BohnDepartment of Internal Medicine V, Comprehensive Cancer Center Innsbruck, Medical University of Innsbruck, 6020 Innsbruck, Austria.
Stefan SchmidtDepartment of Internal Medicine V, Comprehensive Cancer Center Innsbruck, Medical University of Innsbruck, 6020 Innsbruck, Austria.
Eberhard GunsiliusDepartment of Internal Medicine V, Comprehensive Cancer Center Innsbruck, Medical University of Innsbruck, 6020 Innsbruck, Austria.
David NachbaurDepartment of Internal Medicine V, Comprehensive Cancer Center Innsbruck, Medical University of Innsbruck, 6020 Innsbruck, Austria.
Emina JukicInstitute of Human Genetics, Medical University of Innsbruck, 6020 Innsbruck, Austria.
Maurus LocherInstitute of Human Genetics, Medical University of Innsbruck, 6020 Innsbruck, Austria.
Ella WillenbacherDepartment of Internal Medicine V, Comprehensive Cancer Center Innsbruck, Medical University of Innsbruck, 6020 Innsbruck, Austria.
Wolfgang WillenbacherDepartment of Internal Medicine V, Comprehensive Cancer Center Innsbruck, Medical University of Innsbruck, 6020 Innsbruck, Austria.
Thomas WinderDepartment of Internal Medicine II, Feldkirch Academic Teaching Hospital, 6800 Feldkirch, Austria.
Normann SteinerDepartment of Internal Medicine V, Comprehensive Cancer Center Innsbruck, Medical University of Innsbruck, 6020 Innsbruck, Austria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

amplification 1qCD38 antibodycytogenetic high riskdaratumumabmultiple myeloma

Identifiers

PMID40282438
PMCPMC12025356

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.